Douglas Braunstein’s Hudson Executive Capital Selling Atricure Inc. (ATRC)

Page 6 of 8 – SEC Filing

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER

Item 5(c) of this Schedule 13D is amended and restated in its entirety as follows:

“(c)  Exhibit 4 filed herewith, which is incorporated by reference into this Item 5(c) as if restated in full, describes all of the transactions in the Shares that were effected in the past 60 days by the Reporting Persons for the benefit of Mr. Braunstein, Hudson Executive and Management GP. Except as set forth in Exhibit 4, no reportable transactions were effected by any Reporting Person within the last 60 days.”

Item 5(e) of this Schedule 13D is amended and restated in its entirety as follows:

“(e)  The Reporting Persons ceased to be beneficial owners of more than five percent of the Shares on October 5, 2018.”

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS

Item 7 of the Schedule 13D is hereby amended and supplemented by adding a reference to the following exhibit:

Exhibit 4  Schedule of transactions effected during the last 60 days

Follow Atricure Inc. (NASDAQ:ATRC)

Follow Atricure Inc. (NASDAQ:ATRC)

---

or

Subscribe with Google

We may use your email to send marketing emails about our services. Click here to read our privacy policy.